An application made for this job — a tailored resume and cover letter that speak straight to the posting.
CSL Seqirus in Maidenhead, UK, seeks a Case Management Intake Manager to lead the intake quality for adverse event reports. The role is hybrid, three days on site, guiding vendors and ensuring compliance with PV guidelines.
You will build guidance, train the vendor, and own audit readiness, triage accuracy, and cross-functional documentation. A strong pharmacovigilance background and familiarity with Argus will help you succeed.
Based in Maidenhead, UK. Hybrid, 3 days a week on site
Every adverse event report that reaches CSL - from a treating physician, a license partner, a regulatory authority - starts its life in one place: intake. This role owns the quality of that starting point. You'll oversee the vendor responsible for logging and triaging every report that lands in CSL's Global Adverse Events Inbox, making sure each one is captured accurately, on time, and in line with global regulatory requirements. It's a role built on the principle that everything downstream in pharmacovigilance - every safety signal, every regulatory submission - is only as reliable as the intake that fed it.
Regulators don't forgive a missed or mishandled adverse event report, and neither should the systems built to catch them. This role sits at the point where CSL's global safety obligations either hold or don't. Getting intake right - consistently, across every source and every market - is what keeps CSL's regulatory standing intact and, more fundamentally, what keeps the signal-detection process that protects patients working as it should.
You'll be the standard-bearer for how intake gets done - not performing the work yourself, but making sure the vendor who does performs it to the letter of CSL's processes, PV agreements, and global regulatory guidelines. You'll build the guidance that governs their work, train them against it, and be the person accountable when regulators or auditors come asking how the process holds up.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging.
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please click here.
CSL Global Privacy Notice for Job Applicants and Candidates